Depression: An Integrative Approach (2024-2026)
Build on your integrative knowledge, in this course focused on addressing patients with depression. According to the Centers for Disease Control (CDC), in 2020, one in five adults in the US reported a diagnosis of depression by their health provider. Depression is a major contributor to morbidity, mortality, and economic cost. It cuts across socioeconomic boundaries, race, age, and gender and is associated with serious comorbidities such as cardiovascular disease, obesity, chronic pain, diabetes, and substance abuse.
Within conventional practice, the combined use of antidepressant medications and psychotherapy has been considered the standard recommendation for the treatment of all patients with major depressive disorder (MDD). Increasingly, however, the reliance on medications has been questioned in the scientific literature.
For patients to have access to safe and evidence-based integrative approaches, a shift in focus and priorities of funding within the society as a whole are needed. Given the significant impact of depression on patients' lives, safer and more efficacious therapeutic approaches to depression are urgently needed, a fact that has lent momentum to the development of integrative approaches to this complex illness. Expand your ability to support your patients with an integrative approach to depression.
Learning Objectives
At the end of this course, participants will be able to:
- Describe the public health impact of depression, including suicide rates and disparities across age, gender, race, and geographic location.
- Discuss concerns related to medication-focused treatment of depression.
- Review etiological factors for depression.
- Identify symptoms of depression.
- List medical problems and disease states known to cause or are associated with depression.
- Identify medications with depression as potential adverse effects.
- Review conventional treatment approaches for depression.
- Assess the evidence for the safety and benefit of complementary and integrative approaches/practices in the treatment of depression.
- Assess the evidence for the safety and benefit of supplements and botanicals in the treatment of depression.
- Assess the evidence for the effects of lifestyle factors on depression.
- Apply and review integrative medicine approaches in a variety of patient cases with depression.
Curriculum
- Overview
- Treatment Approaches
- Clinical Application
- Course Evaluation and Exam
Completion Requirements
Complete all the coursework, course evaluation, and the final test with a score of 70% or better. Upon successful completion, you will be able to print your certificate of completion.
Target Audience
This activity is intended for physicians, nurse practitioners, nurses, physician assistants, psychologists, and behavioral health professionals in any specialty. In addition, all healthcare professionals who have an interest in an integrative approach to healing are targeted.
Certificate
When all of the above requirements are met (during the agreed-upon timeline), a link for the completion certificate is available to download and print anytime from "My Account." If a specific credit type was selected at registration, your certificate will indicate earned credits.
Disclaimer
This course does not constitute medical advice. Healthcare providers should exercise their own independent medical judgment.
All case studies and patient scenarios in this course are used for illustrative purposes. All depictions of persons (other than faculty) are models and not actual patients.
Depression: An Integrative Approach (2024-2026)
Disclosure & Education Credit Info
Nursing Continuing Professional Development Information
7.25 NCPD Contact Hours for RNs
Current Approval Period - NCPD
May 6, 2024 - May 5, 2026
Completion Requirements
Complete all the coursework, course evaluation, and the final test with a score of 70% or better. You are allowed unlimited re-attempts. Upon successful completion, you will be able to print your certificate of completion.
Relevant Financial Relationship Disclosure Information
Any individuals in a position to control the content of an activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.
Dr. Chiasson has disclosed grant/research support from Pharmavite (relationship has ended).
Dr. Raison has disclosed that he is a consultant for Usona Institute, Novartis, and Otsuka.
Dr. Alschuler has disclosed that she is an advisor for Vitazan; is a speaker for NFH Inc., Gaia Herbs, and OptimalRX (relationship has ended); referral commission through Fullscript; receives sponsorship from Kyowa Hakko & Dr. Ohhira Probiotics, American Biosciences, Essential Formulas, and Integrative Therapeutics; and received grant/research support from Pharmavite (relationship has ended).
Dr. Lee has disclosed that she owns stock in Cybin, MindMed, and Compass Pathways. The content that she authored was reviewed and found unrelated to the business/product lines of these companies. Therefore, Dr. Lee's relationships are not relevant to the content she authored for this course.
All other individuals in a position to control the content of this activity, including faculty, planners, reviewers, or others, have disclosed that they have no relevant financial relationships with ineligible companies.
This nursing continuing professional development activity was approved by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
ACCME/AMA PRA Accreditation and CME Designation Statement
The University of Arizona College of Medicine – Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Arizona College of Medicine – Tucson designates this enduring material for a maximum of 7.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Current Approval Period - CME
May 6, 2024 - May 5, 2026
Most Recent Review by Author: January 31, 2024
Completion Requirements
Complete all the coursework, course evaluation, and the final test with a score of 70% or better. You are allowed unlimited re-attempts. Upon successful completion, you will be able to print your certificate of completion.
Relevant Financial Relationship Disclosure Information
University of Arizona College of Medicine – Tucson Continuing Medical Education adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.
Dr. Chiasson has disclosed grant/research support from Pharmavite (relationship has ended).
Dr. Raison has disclosed that he is a consultant for Usona Institute, Novartis, and Otsuka.
Dr. Alschuler has disclosed that she is an advisor for Vitazan; is a speaker for NFH Inc., Gaia Herbs, and OptimalRX (relationship has ended); referral commission through Fullscript; receives sponsorship from Kyowa Hakko & Dr. Ohhira Probiotics, American Biosciences, Essential Formulas, and Integrative Therapeutics; and received grant/research support from Pharmavite (relationship has ended).
Dr. Lee has disclosed that she owns stock in Cybin, MindMed, and Compass Pathways. The content that she authored was reviewed and found unrelated to the business/product lines of these companies. Therefore, Dr. Lee's relationships are not relevant to the content she authored for this course.
All other individuals in a position to control the content of this activity, including faculty, planners, reviewers, or others, have disclosed that they have no relevant financial relationships with ineligible companies.
Commercial Support
There is no commercial support for this activity.
Faculty / Authors
Allison Lee, MD; Owner, Private Practice - C. Allison Lee, M.D.
Lewis Mehl-Madrona, MD; Physician, Acadia Psychiatric Hospital, Bangor, ME; Physician, Family Medicine Residency, Eastern Maine Medical Center, Bangor, ME
Lise Alschuler, ND; Professor of Clinical Medicine, University of Arizona; Assistant Director of the Fellowship in Integrative Medicine, Andrew Weil Center for Integrative Medicine
Noshene Ranjbar, MD; Medical Director, Integrative Psychiatry Clinic, Banner-UA Tucson; Medical Director, Child and Adolescent Psychiatry Clinic, Banner-UA Tucson; Co-Director of Integrative Medicine in Residency-Psychiatry, Department of Psychiatry, University of Arizona. Faculty, Center for Mind-Body Medicine; Faculty, Andrew Weil Center for Integrative Medicine
Charles Raison, MD; Professor, Department of Psychiatry, School of Medicine and Public Health: University of Wisconsin-Madison.
Planning Committee
Ann Marie Chiasson, MD, MPH, ABOIM; Director of Education and the Fellowship, University of Arizona Center for Integrative Medicine.
Elizabeth Knight, PhD, DNP, FNP-C; Integrative Health Coach, Flower Power Health and Nurse Practitioner, Reed College